Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Viruses ; 9(11)2017 10 26.
Article in English | MEDLINE | ID: mdl-29072600

ABSTRACT

The Protoparvovirus (PtPV) genus of the Parvoviridae family of viruses includes important animal pathogens and reference molecular models for the entire family. Some virus members of the PtPV genus have arisen as promising tools to treat tumoral processes, as they exhibit marked oncotropism and oncolytic activities while being nonpathogenic for humans. The PtPVs invade and replicate within the nucleus making extensive use of the transport, transcription and replication machineries of the host cells. In order to reach the nucleus, PtPVs need to cross over several intracellular barriers and traffic through different cell compartments, which limit their infection efficiency. In this review we summarize molecular interactions, capsid structural transitions and hijacking of cellular processes, by which the PtPVs enter and deliver their single-stranded DNA genome into the host cell nucleus. Understanding mechanisms that govern the complex PtPV entry will be instrumental in developing approaches to boost their anticancer therapeutic potential and improving their safety profile.


Subject(s)
Cell Nucleus/virology , Parvovirus/physiology , Virus Internalization , Active Transport, Cell Nucleus , Animals , Capsid/metabolism , Capsid Proteins/genetics , DNA, Viral/genetics , DNA, Viral/metabolism , Genome, Viral , Host-Pathogen Interactions , Humans , Models, Molecular , Oncolytic Virotherapy , Parvovirus/genetics , Virus Replication
2.
Expert Rev Hematol ; 9(1): 107-13, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26523940

ABSTRACT

BACKGROUND: Hb H disease is an alpha-thalassemia (α-thal) syndrome characterized by chronic hemolytic anemia that occurs when three of total four α-globin genes lost their function due to completely deletions or different kind of mutations. OBJECTIVE: We here described 66 patients who have been diagnosed for Hb H disease during the last five years in our center. The genotypes involving point mutations present more severe phenotype than deletional forms that make them of primary important to health management. STUDY DESIGN: Hb H subjects carry different α-globin genotypes including deletional and non-deletional mutations showing heterogenous clinical manifestations. RESULTS: The Hb H patients presenting a wide range of phenotype carried different deletional, non-deletional mutations or compound heterozygosity of them. CONCLUSION: We emphasize the importance of some point mutations responsible for more severe form of Hb H disease in Iranian population and the necessity for consideration of prenatal diagnosis (PND) in high-risk couples.


Subject(s)
Hemoglobins, Abnormal/genetics , Point Mutation/genetics , Adolescent , Adult , Child , Humans , Middle Aged , Young Adult
3.
Hemoglobin ; 39(3): 201-6, 2015.
Article in English | MEDLINE | ID: mdl-26084319

ABSTRACT

The 3.7 kb triplicated α-globin gene (ααα(anti 3.7)) mutation has been found in most populations. It results from an unequal crossover between misaligned homologous segments in the α-globin gene cluster during meiosis. The pathophysiology and clinical severity of ß-thalassemia (ß-thal) are associated with the degree of α chain imbalance. The excess of α-globin chains plays an important role in the pathophysiology of ß-thal. When heterozygous/homozygous ß-thal coexists with an α gene numerical alteration, the clinical and hematological phenotype of thalassemia could change to mild anemia in case of an α deletion (-α/αα) or severe anemia in the case of an α triplication (αα/ααα). The coexistence of an ααα(anti 3.7) triplication is considered an important factor in the severity of ß-thal, exacerbating the phenotypic severity of ß-thal by causing more globin chain imbalance. This study shows that the ααα(anti 3.7) triplication is an important factor in the causation of ß-thal intermedia (ß-TI) in heterozygous ß-thal. This type of phenotype modification has rarely been observed and reported in the Iranian population. Here we report the coinheritance of a triplicated α-globin gene arrangement and heterozygous/homozygous ß-thal in 23 cases, presenting with a ß-TI or ß-thal major (ß-TM) phenotype. Some of these patients were considered to have a mild ß-TI phenotype as they needed no blood transfusions; some occasionally received blood transfusions in their lifetime (for example on delivery) but some are dependent on regular blood transfusions (every 20 to 40 days). Our study was focused on the importance of detecting the α-globin gene triplication in genotype/phenotype prediction in Iranian thalassemia patients.


Subject(s)
Epistasis, Genetic , Gene Dosage , Mutation , alpha-Globins/genetics , beta-Globins/genetics , beta-Thalassemia/genetics , Adult , Blood Transfusion , Erythrocyte Indices , Female , Genotype , Humans , Iran , Male , Middle Aged , Phenotype , beta-Thalassemia/diagnosis , beta-Thalassemia/therapy
4.
Hemoglobin ; 38(3): 153-7, 2014.
Article in English | MEDLINE | ID: mdl-24826790

ABSTRACT

Our study aimed to determine the number of couples with normal hemoglobin (Hb) electrophoresis and low-borderline hematological values, which may come up with a clinically critical status in their offspring. The number of couples at risk for severe α-thalassemia (α-thal) needed to be estimated before recommending genetic counseling and prenatal diagnosis (PND). During the past 14 years, from at least 7000 referrals, 754 couples were investigated for α-thal by direct mutation detection methods followed by reverse strip assay and α-globin gene sequencing for inconclusive cases. Detection of silent ß-thalassemia (ß-thal) mutations was done in suspected cases by complete ß-globin gene sequencing. We were able to provide a molecular diagnosis in 87.3% (658/754) of couples. A total of 9.1% (60/658) may have a clinically significant hemoglobinopathy in their offspring. Significant conditions included hydrops fetalis (20.0%; 12/60), certain Hb H (ß4) genotypes (78.3%; 47/60) and ß-thal intermedia (ß-TI) (1.7%; 1/60). The diagnostic flowchart for couples with microcytic hypochromic anemia in countries with a high prevalence of hemoglobinopathies should include α and ß gene sequencing. As our results indicate, every nine out of 100 of these couples will face significant hemoglobinopathies and every two out of 100 can carry Hb Bart's (γ4) hydrops fetalis in their pregnancies. For such cases, PND should be utilized to allow the carrier couples to decide whether or not to abort the fetus.


Subject(s)
Genetic Counseling/methods , Mutation , alpha-Thalassemia/genetics , beta-Globins/genetics , DNA Mutational Analysis , Female , Humans , Iran/epidemiology , Male , Retrospective Studies , alpha-Thalassemia/epidemiology
5.
Hemoglobin ; 37(2): 148-59, 2013.
Article in English | MEDLINE | ID: mdl-23402770

ABSTRACT

α-Thalassemia (α-thal) is usually caused by deletions on the α-globin gene cluster and the role of point mutations is less well investigated. In the present study, a total of 1048 individuals with hypochromic microcytic anemia, who did not present the most common α-thal deletions, were referred for α-globin gene DNA sequencing. The nucleotide changes were studied and a total of five new mutations was identified, of which three were located on the α2 gene [codon7 (Lys→Stop), codon 34 (Leu→Pro) and codon 83 (Leu→Arg)] and two on the α1 gene [IVS-I-116 (A>G) and codon 44 (+C)]. These novel mutations not only explain new findings by molecular analysis of the α-globin gene but also have clinical importance due to their changes in α-globin production in means of decreased hemoglobin (Hb) related values. Moreover, considerations of its role in combination with other mutations, and the possibility of causing Hb H (ß4) are yet to be studied.


Subject(s)
Mutation , alpha-Globins/genetics , alpha-Thalassemia/genetics , Adult , Aged , Aged, 80 and over , Codon/genetics , DNA Mutational Analysis , Family Health , Female , Genetic Testing , Geography , Humans , Iran/epidemiology , Male , Prevalence , Young Adult , alpha-Thalassemia/diagnosis , alpha-Thalassemia/epidemiology
6.
Hemoglobin ; 37(1): 56-64, 2013.
Article in English | MEDLINE | ID: mdl-23215864

ABSTRACT

In an attempt to determine the spectrum of α-thalassemia (α-thal) mutations in the Kurdish population of Northeastern (NE) Iraq, a total of 101 unrelated adults with unexplained hypochromia and/or microcytosis were enrolled. α-Thalasssemia mutations were characterized by gap polymerase chain reaction (gap-PCR), multiplex PCR (m-PCR) and reverse hybridization and sequencing for both α genes. A total of nine α-thal mutations were characterized including four deletional ones: -α(3.7) (rightward), - -(MED-I), -(α)(20.5), -α(4.2) (leftward) and five nondeletional ones: α(polyA1)α, αα(Adana), α(-5 nt)α, α(CS)α and α(polyA2)α. These determinants were arranged in 12 different genotypes, the most frequent of which were: -α(3.7)/αα, - -(MED-I)/αα, -α(3.7)/-α(3.7), α(polyA1)α/αα, αα(Adana)/αα and -(α)(20.5)/αα. This pattern is similar to that reported in Turkey, western (W) Iran, Cyprus and Greece, and to some extent, different from the pattern observed in the Arabian Peninsula.


Subject(s)
Mutation , alpha-Globins/genetics , alpha-Thalassemia/genetics , Adult , Genotype , Humans , Iraq/epidemiology , Iraq/ethnology , Multiplex Polymerase Chain Reaction , Polymerase Chain Reaction , alpha-Thalassemia/epidemiology , alpha-Thalassemia/ethnology
7.
J Pak Med Assoc ; 62(4): 396-8, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22755290

ABSTRACT

We report of an Iranian family with history of a rare haemoglobin variant, Haemoglobin J associated with alpha thalassemia, discovered while performing premarital thalassemia screening. In the present study we report the first case of haemoglobin J-Toronto [alpha 5 (A3) Ala > Asp] on -globin gene, found in a 16-year-old female from Mazandaran Province, North of Iran. Further investigation characterized the same mutation for mother and brother of the proband, whilst mother was also a carrier of an alpha thalassemia gene mutation (-alpha3.7). Haemoglobin J-Toronto was previously just reported from Canada and has not been found in any part of Iran.


Subject(s)
Hemoglobin J/genetics , alpha-Thalassemia/diagnosis , alpha-Thalassemia/genetics , Female , Humans , Iran , Male
8.
Hemoglobin ; 36(4): 371-80, 2012.
Article in English | MEDLINE | ID: mdl-22686296

ABSTRACT

Hydroxyurea (HU), a drug which can reactivate fetal hemoglobin (Hb F) production, is frequently prescribed to ß-thalassemia (ß-thal) patients. However, transfusion requirements of only a subset of patients are reduced upon HU treatment. Because of its potential side-effects, targeted prescription of HU is imperative. To identify genetic markers that correlate with drug response, we have carried out a retrospective association study of single nucleotide polymorphisms (SNPs) in three Hb F quantitative trait loci (QTLs): the XmnI polymorphism, BCL11A, and the HBS1L-MYB intergenic region, with the response to HU in a cohort of 81 transfusion-dependent Iranian ß-thal patients. An increase in blood transfusion intervals post-therapy was used to measure drug response. Our results suggest that presence of the XmnI T/T genotype or the BCL11A rs766432 C allele correlates strongly with response to HU (p <0.001). Accordingly, these markers may be used to accurately predict the HU response of Iranian ß-thal patients.


Subject(s)
Fetal Hemoglobin/genetics , Hydroxyurea/therapeutic use , Polymorphism, Single Nucleotide , beta-Thalassemia/drug therapy , beta-Thalassemia/genetics , Adult , Antisickling Agents/therapeutic use , Blood Transfusion , Female , Gene Frequency , Genotype , Humans , Iran , Male , Middle Aged , Prognosis , Retrospective Studies , Treatment Outcome , Young Adult , beta-Thalassemia/therapy
9.
J Med Case Rep ; 6: 47, 2012 Feb 06.
Article in English | MEDLINE | ID: mdl-22309992

ABSTRACT

INTRODUCTION: Hemoglobin Q-Iran (α75Asp→His) is an important member of the hemoglobin Q family, molecularly characterized by the replacement of aspartic acid by histidine. The first report of hemoglobin Q-Iran and the nomenclature of this hemoglobinopathy dates back to 1970. Iran is known as a country with a high prevalence of α- and ß-thalassemia and different types of hemoglobinopathy. Many of these variants are yet to be identified as the practice of molecular laboratory techniques is limited in this part of the world. Applying such molecular methods, we report the first hemoglobin Q-Iran cases in Northern Iran. CASE PRESENTATION: An unusual band was detected in an isoelectric focusing test and cellulose acetate electrophoresis of a sample from a 22-year-old Iranian man from Mazandaran Province. Capillary zone electrophoresis analysis identified this band as hemoglobin Q. A similar band was also detected in his mother's electrophoresis (38 years, Iranian ethnicity). The cases underwent molecular investigation and the presence of a hemoglobin Q-Iran mutation was confirmed by the amplification refractory mutation system polymerase chain reaction method. Direct conventional sequencing revealed a single guanine to cytosine missense mutation (c.226G > C; GAC >CAC) at codon 75 in the α-globin gene in both cases. CONCLUSION: The wide spectrum and high frequency of nondeletional α-globin mutations in Mazandaran Province is remarkable and seem to differ considerably from what has been found in Mediterranean populations. This short communication reports the first cases of patients with hemoglobin Q found in that region.

10.
Turk J Gastroenterol ; 22(4): 433-6, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21948578

ABSTRACT

Acute pancreatitis is a rare, but fatal, manifestation of systemic lupus erythematosus. Only 10 systemic lupus erythematosus-associated pancreatitis cases were found in a search of published articles. We report a 24-year-old woman without significant medical history, who was admitted with abdominal pain, nausea and vomiting, which was diagnosed as pancreatitis. It was discovered to be the initial presentation of systemic lupus erythematosus. The first time she was admitted, she recovered with conservative management and steroid therapy. Two months later, she was readmitted to our hospital with symptoms and signs of acute abdomen, which was attributed to her discontinuation of the therapeutic regimen with corticosteroids just after her previous discharge. She underwent laparotomy twice for signs of peritonitis. Despite administration of a monoclonal antibody, rituximab, she died due to the progression of systemic lupus erythematosus activity.


Subject(s)
Lupus Erythematosus, Systemic/diagnosis , Pancreatitis/diagnosis , Abdominal Pain/etiology , Adult , Cause of Death , Colostomy , Cyclophosphamide/administration & dosage , Drug Therapy, Combination , Endosonography , Female , Glucocorticoids/administration & dosage , Humans , Immunosuppressive Agents/administration & dosage , Laparotomy , Lupus Erythematosus, Systemic/drug therapy , Lupus Erythematosus, Systemic/mortality , Methylprednisolone/administration & dosage , Nausea/etiology , Pancreatitis/drug therapy , Pancreatitis/mortality , Tomography, X-Ray Computed , Vomiting/etiology , Young Adult
11.
Hemoglobin ; 35(1): 40-6, 2011.
Article in English | MEDLINE | ID: mdl-21250880

ABSTRACT

Thalassemia is the most common genetic disorder in Iran. Some α-globin genotypes leading to Hb H disease may cause severe anemia and dependence on regular blood transfusions. In this study, 40 patients were analyzed for the molecular basis and the genotype-phenotype correlation of Hb H disease in Iran. α-Globin molecular analysis was performed by polymerase chain reaction (PCR) followed by agarose gel electrophoresis, reverse hybridization test strips or DNA sequencing. The most frequently observed α-globin genotypes were -α(3.7)/- -(MED) in 10 patients (25%), - -(20.5)/α(-5nt)α in six patients (15%) and - -(20.5)/-α(3.7) in four patients (10%). A subset of the identified Hb H genotypes, including - -(MED)/α(CS)α, - -(MED)/α(PolyA2)α and α(CS)α/α(CS)α, was associated with a need for regular or irregular blood transfusions. Our findings provide a basis for predicting phenotype severity by identifying the Hb H genotype and making more selective decisions for prenatal diagnosis.


Subject(s)
Hemoglobin H/genetics , alpha-Globins/genetics , alpha-Thalassemia/genetics , Adult , Anemia/genetics , Blood Transfusion , Female , Genetic Association Studies , Genotype , Hematologic Tests , Humans , Iran , Male , Phenotype , Polymerase Chain Reaction , Predictive Value of Tests , Pregnancy , Prenatal Diagnosis , Severity of Illness Index , alpha-Thalassemia/diagnosis , alpha-Thalassemia/physiopathology
12.
Hemoglobin ; 34(5): 469-76, 2010.
Article in English | MEDLINE | ID: mdl-20854121

ABSTRACT

A random 123 carriers of ß-thalassemia (ß-thal), identified by the Sulaimaniyah Provincial Premarital Screening Program in northeastern Iraq, were screened for ß-thal mutations using multiplex polymerase chain reaction followed by reverse hybridization StripAssay and direct sequencing. A total of 11 different ß-thal mutations was identified in the studied samples, of which eight represented 96% of the mutated ß-globin genes. These were IVS-II-1 (G>A), IVS-I-110 (G>A), codon 8 (-AA), codons 8/9 (+G), IVS-I-5 (G>C), codon 5 (-CT), IVS-I-6 (T>C) and IVS-I-1 (G>A). Other mutations were less common or sporadic. There were some notable differences in frequencies of various mutations in comparison to other eastern Mediterranean populations, as well as with previous studies of Iraqi Kurds. The latter illustrate the relative heterogeneity of the mutations distributed in Iraq, and the need to screen other areas of the country, to ensure the establishment of an effective prenatal diagnosis program.


Subject(s)
Mutation , beta-Globins/genetics , beta-Thalassemia/genetics , Adolescent , Adult , DNA Mutational Analysis , Female , Gene Frequency , Genetic Testing , Genotype , Geography , Humans , Iraq , Male , Middle Aged , Polymerase Chain Reaction/methods , Young Adult , beta-Thalassemia/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...